Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale

Advances in Therapy

Jul 25

Written By Matthijs Versteegh

SchizophreniaQuality of life

Matthijs Versteegh

Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model

The value of health in a cost-effectiveness analysis: theory vs practice